CereVasc secures $85 million in Series C funding to advance development of its eShunt System, designed to treat normal pressure hydrocephalus.
Amount Raised
$85 Million
Round Type
Series C
BostonBiotechnologyInvestors
Description
CereVasc, Inc. secured $85 million in an over-subscribed Series C financing round to support the development of its eShunt® System, a medical device designed to treat normal pressure hydrocephalus (NPH). The company intends to use the capital to advance the clinical and regulatory progress of the device. The financing round attracted significant investor interest, resulting in the over-subscription of the offering
Quick answer
CereVasc raised $85 Million in a Series C round, dated June 4, 2026. Investors: Perceptive Xontogeny Venture Funds, Bain Capital Life Sciences, Medtronic and Piper Sandler Merchant Banking. CereVasc is based in Boston, Massachusetts, United States.
- How much did CereVasc raise?
- CereVasc raised $85 Million in a Series C round on June 4, 2026.
- Who invested in CereVasc?
- Perceptive Xontogeny Venture Funds, Bain Capital Life Sciences, Medtronic and Piper Sandler Merchant Banking are named as investors in this round.
- What does CereVasc do?
- Located in Massachusetts’ healthcare hub, CereVasc, Inc., is a clinical stage, medical device company focused on the development of novel, minimally invasive treatments for patients with neurological diseases.
- Where is CereVasc based and how big is it?
- CereVasc is based in Boston, Massachusetts, United States.
- Who are the decision-makers at CereVasc?
- Fundz holds 2 contacts at CereVasc, including the Senior Director, Marketing & Communications. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as CereVasc that raised within 45 days of this round, from Fundz verified event records.
- Sielo Robotics raised $1M (Seed) on July 19, 2026.
- Humanoid raised $150M (Series A) on July 18, 2026.
- Sightera Biosciences raised $3.4M (Pre-Seed) on July 17, 2026.
- Glucotrack raised an undisclosed amount on July 17, 2026.
- ME Therapeutics Holdings raised $457K (Post-IPO Equity) on July 17, 2026.
- Oro Muscles raised $350K (Seed) on July 17, 2026.
Who to call at CereVasc, and when
A new round usually means CereVasc is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CereVasc raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CereVasc, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CereVasc. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CereVasc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
CereVasc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.